Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ward Photonics has developed and commercialized noninvasive medical light therapy devices—UltraSlim® for immediate fat loss and UltraSmooth® for cellulite treatment. These devices are FDA-cleared, with clinical results showing average fat loss per session without pain or side effects. The technology uses red light to trigger natural body processes for fat removal. No traditional drug development pipeline; all products are commercial-stage medical devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ward Photonics.